Sable Biotechnology Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.94M
- Investors
-
4
Sable Biotechnology General Information
Description
Developer of a biomedical data platform designed to provide drug safety insights. The company's platform leverages artificial intelligence and large language models to generate proprietary datasets and extract data from unstructured trial reports, enabling the pharmaceutical industry to reduce the cost and time taken to produce toxicology drug safety reports.
Contact Information
Website
www.sablebio.comCorporate Office
- 10b Powerscroft Road
- London E5 0PU
- England, United Kingdom
Corporate Office
- 10b Powerscroft Road
- London E5 0PU
- England, United Kingdom
Sable Biotechnology Timeline
Sable Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 11-Feb-2026 | $3.94M | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 04-Nov-2024 | Completed | Generating Revenue | |||
| 1. Seed Round | 06-Feb-2024 | $1.91M | $1.91M | Completed | Generating Revenue |
Sable Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Preferred | ||||||||
| Seed Preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Sable Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sable Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sable Biotechnology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MMC Ventures | Venture Capital | Minority | ||
| CAS (Columbus) | Accelerator/Incubator | Minority | ||
| Episode 1 Ventures | Venture Capital | Minority | ||
| Seedcamp | Venture Capital | Minority |
Sable Biotechnology FAQs
-
When was Sable Biotechnology founded?
Sable Biotechnology was founded in 2023.
-
Where is Sable Biotechnology headquartered?
Sable Biotechnology is headquartered in London, United Kingdom.
-
What is the size of Sable Biotechnology?
Sable Biotechnology has 6 total employees.
-
What industry is Sable Biotechnology in?
Sable Biotechnology’s primary industry is Other Healthcare Technology Systems.
-
Is Sable Biotechnology a private or public company?
Sable Biotechnology is a Private company.
-
What is the current valuation of Sable Biotechnology?
The current valuation of Sable Biotechnology is .
-
What is Sable Biotechnology’s current revenue?
The current revenue for Sable Biotechnology is .
-
How much funding has Sable Biotechnology raised over time?
Sable Biotechnology has raised $5.85M.
-
Who are Sable Biotechnology’s investors?
MMC Ventures, CAS (Columbus), Episode 1 Ventures, and Seedcamp have invested in Sable Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
